Business Context and Reporting Period
This Form 8-K is filed by BioSig Technologies, Inc. (not Streamex Corp.) for the reporting period of July 23, 2024. The filing addresses a significant change in the trading venue for the company's common stock.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and trading status events.
Material Changes
- Trading Venue Change: On July 23, 2024, the company commenced trading its common stock on the OTCQB (operated by OTC Markets Group, Inc.).
- Nasdaq Delisting: Trading was previously suspended on The Nasdaq Stock Market LLC effective June 12, 2024, following a delisting decision dated June 10, 2024.
- Appeal Status: The company filed an appeal with the Nasdaq Listing and Hearing Review Council on July 10, 2024, and is currently awaiting a decision.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management commentary on future performance, or specific risk factors beyond the ongoing uncertainty of the Nasdaq delisting appeal. The primary contingency is the potential reinstatement of Nasdaq listing versus continued trading on the OTCQB.
Investor Verification Checklist
- Verify the current trading symbol and venue (OTCQB) for BioSig Technologies, Inc.
- Monitor the status of the appeal filed with the Nasdaq Listing and Hearing Review Council.
- Confirm the impact of the delisting on liquidity and market access for existing shareholders.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).